Particle Technology Labs (PTL) has established cGMP compliance for Nanoparticle Tracking Analysis (NTA), which is now available on a contract basis to the pharma industry. NTA has been adopted for both research-based projects and as a quality control tool for regulated industries. PTL’s NanoSight LM10-HSB instrument is certified cGMP as of June 4, 2013, and expands the company’s analytical capabilities by allowing quantification of particle concentrations in the submicron range.
 
William Kopesky, PTL’s director of Analytical Services, said, “We are excited to have this new technology in our lab. As a cGMP qualified instrument, the NanoSight LM10-HSB expands our capabilities to our regulated clients, providing them with an accurate particle concentration and size device in the submicron range.”
 
Mr. Kopesky added, “NTA has significantly better resolution than DLS, as we have verified here at PTL. Its ability to count particles in the submicron range constitutes a paradigm shift. Access to NTA technology is a benefit for several applications. Thanks to the sensitivity of NTA technology, PTL can now detect an even lower level of submicron particles.”